You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 3月9日港股收盤

根據uSMART輿情監測數據,9日港股交易時段,市場關注指數最高的5只股票是香港交易所、中芯國際、比亞迪股份、吉利汽車、藥明生物。

3月9日—港股關注排行TOP5

輿情變化榜單

香港交易所

個股K線圖

關注度第一爲香港交易所,該股今日收盤下跌2.15%,報於329.00港元。近5個交易日累計下跌9.57%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

港交所隨市下挫4% 遭大摩削目標價至430元

港交所再跌超5% 大摩稱短期週期性因素進一步惡化 下調目標價近15%

中芯國際

個股K線圖

關注度第二爲中芯國際,該股今日收盤上漲2.32%,報於17.64港元。近5個交易日累計下跌6.37%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

中芯國際AH股齊升,前兩個月淨利潤同比增長95%

中芯國際高開近4% 前兩月淨利同比大增94.9% 已超去年一季度

比亞迪股份

個股K線圖

關注度第三爲比亞迪股份,該股今日收盤上漲3.21%,報於189.90港元。近5個交易日累計下跌20.61%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

車企2月銷量揭曉!比亞迪領跑新能源,吉利、奇瑞衝進“萬輛陣營”!

王傳福卸任青島市比亞迪汽車有限公司董事長

吉利汽車

個股K線圖

關注度第四爲吉利汽車,該股今日收盤上漲4.82%,報於11.74港元。近5個交易日累計下跌17.44%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

汽車股集體上漲,吉利汽車漲4.6%

吉利汽車反彈漲2.68% 2月純電動汽車銷量同比增長1430%

藥明生物

個股K線圖

關注度第五爲藥明生物,該股今日收盤下跌6.98%,報於52.00港元。近5個交易日累計下跌21.27%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

恆指跌幅曾擴至逾500點再尋底 港交所、安踏、李寧及藥明生物挫5%至10%

快訊:醫藥外包概念股下跌 藥明生物跌超9%藥明康德跌近7%

此外,監測期內有2只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

3月9日—港股輿情轉折預警

輿情變化榜單

比亞迪股份

個股K線圖

比亞迪股份輿情扭轉指數達99,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

車企2月銷量揭曉!比亞迪領跑新能源,吉利、奇瑞衝進“萬輛陣營”!

王傳福卸任青島市比亞迪汽車有限公司董事長

藥明生物

個股K線圖

藥明生物輿情扭轉指數達98,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。

其中較被市場關注的消息有:

恆指跌幅曾擴至逾500點再尋底 港交所、安踏、李寧及藥明生物挫5%至10%

快訊:醫藥外包概念股下跌 藥明生物跌超9%藥明康德跌近7%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account